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This aim of this study was to evaluate the rate of surgical site infection (SSI) in patients 
undergoing Total Knee Arthroplasty (TKA), to improve our understanding of the associations 
between infection rate and obesity.  
 
Methods  
Data was reviewed for 839 primary TKA procedures performed at a National Arthroplasty 
Centre over one year (April 2007-March 2008). SSI data was collected at 30 days and one 
year post-operatively. Patients were grouped guided by the WHO classifications of obesity; 
normal (BMI < 25.0), overweight (BMI 25.00 – 29.99), obese class I (BMI 30.00 – 34.99), 
obese class II (BMI 35.00 – 39.99), obese class III (BMI ≥ 40.00). Statistical significance was 
assessed by Fisher’s Exact Test.  
 
Results 
When grouped by BMI, 30.9% of patients were obese class I, 19.0% obese class II and 8.7% 
obese class III. Of the total cohort, 22 patients (2.6%) had superficial SSI and 13 (1.5%) had 
deep SSI. When comparing the obese class III cohort to all other cohorts (non-obese class 
III), the odds ratios for superficial SSI was 4.20 (95% CI [1.59, 11.09]; p = 0.009) and deep 











rate was higher in females (8.9%) than males (5.9%), yet deep SSI demonstrated the opposite, 
with a higher occurrence in males (11.8%) compared to females (5.4%). 
 
Conclusion  
This study suggests that obese class III TKA patients are at increased odds of superficial and 
deep SSI compared to other BMI cohorts. Interestingly, male obese class III patients 
demonstrated a higher rate of deep infection compared to their female counterparts. However, 
it must be noted that study findings are limited as confounders were unable to be accounted 
for in this retrospective study design. 
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1. Introduction  
Overweight and obesity are worldwide health epidemics, placing burden on healthcare 
systems. According to figures published by the Scottish government, in 2015, 65% of 
Scottish adults aged 16 years or older were overweight, and 29% of these adults were obese.1 
Equally as alarming, recent Australian reports have suggested increasing rates of overweight 
and obesity with age, displaying an increase from 39% of those aged 18-24, to 74% of people 
aged 65-74 years.2  
Obesity has been shown to closely align with the incidence of osteoarthritis,3,4 whereby obese 
individuals are more likely to require total joint arthroplasty at a younger age and have a 
higher revision rate.5-7 Total joint replacement, although associated with excellent gains in 
quality of life, is a highly invasive surgery that is not devoid of complications, such as those 
associated with superficial or deep surgical site infection (SSI). The most common cause of 
SSI appears to be Staphylococcus aureus,8,9 however some coagulase-negative Staphlococci 
have been reported in studies at similar or greater rates than S. aureus.10,11 The bacterial 
origin of SSI is usually identified as a patient’s own skin flora12 and nasal carriage of S. 
aureus is a major factor for SSI.13  
There are two types of commonly reported SSI; superficial infection which typically occurs 
up to 30 days after surgery; and deep infection, which can occur up to one year after surgery. 
Superficial infection is typically treatable with a course of antibiotics and occasionally 
debridement, which often resolves with minimal complications.14 However, deep infection 
can require one or more surgeries, with revision of part or the complete prostheses, and 
occasionally arthrodesis.15,16 Such surgeries come with significant morbidity to the patient. 
Furthermore, revision surgeries are expensive and complex, with infection responsible for 
22.5% of primary total knee revisions.17  
Obesity is considered a risk factor for SSI, demonstrating the paradigm that not only are 
obese patients more likely to require arthroplasty, they are at a greater risk of complications, 
which should be considered before surgery.12,18-20 However, the literature remains 
contentious,21 as studies have illustrated both no significant increases in infection risk,22-25 or 
highly significant increases in risk.26-29 These controversies exist, partly, as the link between 
obesity and infection remains unclear.30 As obesity is typically associated with underlying co-











additional complications may be contributors to poor surgical outcomes such as SSI.32,33 In 
addition, the use of body mass index (BMI) as a sole measure of obesity may not always 
accurately illustrate these complexities. Well-acknowledged limitations including the 
inability to distinguish between adipose tissue and lean mass, or account for body fat type and 
distribution result in the potential for misdiagnosis of obesity when using BMI.34 
Nevertheless BMI remains a widely adopted measure for categorisation of obesity. 
Obesity is a pro-inflammatory state of increased chronic and low-grade inflammation, with 
the potential to augment the post-operative inflammatory response.35 This altered 
inflammatory state has the potential to alter the way in which obese individuals respond to 
infection.36-38 However, to better understand the molecular link between obesity and SSI, 
there needs to be improved clarity on the correlation between incidence and type of SSI in 
obese TKA patients. Therefore, this study retrospectively evaluated BMI and the incidence of 
SSI in 839 patients who underwent routine primary TKA at the Golden Jubilee National 
Hospital of Glasgow, to assess any potential correlation between obesity and SSI, to improve 




2.1 Patient recruitment 
In this study, 839 patients who had previously undergone routine primary TKA at the Golden 
Jubilee National Hospital of Glasgow were retrospectively evaluated for BMI levels and 
incidence of SSI over a one year period, April 2007 to March 2008. SSI data was collected 
from two sources. Infection data was collected prospectively by the independent hospital 
Infection Control Team for in-patient stays and post-discharge up to 30 days post-operatively. 
This data was available for all patients and issued in monthly reports, which was used to 
identify superficial SSI up to 30 days post-operatively. Data was also sourced from ISD 
(Information Services Division of NHS Scotland) who independently collected all re-
admissions to any hospital in Scotland for infection within one year of operation. This data 
was used to identify all cases of deep SSI within one year. 
Patient records were obtained and the results recorded for SSI and BMI. Patients were 











according to BMI: normal (BMI < 25.0), overweight (BMI 25.00 – 29.99), obese class I 
(BMI 30.00 – 34.99), obese class II (BMI 35.00 – 39.99) and obese class III (BMI ≥ 40.00).39 
BMI is expressed in units of kg/m2. 
2.2 Data collection 
Data was analysed by comparing SSI occurrence during the follow-up period of one year 
post-operative and the type of SSI that was found. Deep SSI (DSSI) was classed as any 
infection to the operative area that required a re-admission to hospital, up to one year 
following surgery, as per the Scottish Arthroplasty Project. Superficial SSI (SSSI) was 
classed as any infection that did not require re-hospitalisation and occurred during the first 30 
days post-operative. Patients were grouped by BMI cohort as described in section 2.1. 
Additionally, for data analyses SSSI and DSSI was assessed between the obese class III (BMI 
≥ 40.00) and non-obese class III, which was inclusive of all cohorts with a BMI < 40.00. 
Analyses were also performed between the obese cohort (all patients with a BMI ≥ 30.00) 
and the non-obese cohort (all patients with a BMI < 30.00). 
2.3 Statistical analyses 
Statistical analyses were performed using GraphPad Prism (Version 6). Comparisons were 
made between obese class III and non-obese class III using Fisher’s Exact Test (2-tailed) to 
determine the odds ratio (OR) of SSSI or DSSI incidence. Comparisons were also made 
between obese and non-obese cohorts to determine the odds ratio of SSSI or DSSI incidence. 
Where the confidence interval (CI) did not cross the y-axis, significance was achieved 













3.1 Patient characteristics and BMI 
There were a total of 839 TKAs performed over the selected study period and BMI 
measurements were available for all 839 patients, with a mean BMI of 31.9. When grouped 
by BMI class, 9.8% of patients had normal BMI, 31.7% were overweight, 30.9% were obese 
class I, 19.0% were obese class II and 8.7% were obese class III. Of this cohort of patients, 
498 were female and 341 were male, with females found to have a higher mean BMI. A 
breakdown of gender distribution across BMI groups is provided in Figure 1. 
3.2 Infection rate with BMI 
There were 22 patients with SSSI at 30 days and 13 with DSSI at one year, with an overall 
SSSI rate of 2.6% and DSSI rate of 1.5%. The obese class III group had higher rates of both 
SSSI (8.2%) and DSSI (6.8%) when compared to all other BMI groups (Table 1). 
Furthermore, the obese class III group were at 4.20 times greater odds of SSSI (95% CI [1.59, 
11.09]; p = 0.009) and 6.97 times greater odds of DSSI (95% CI [2.22, 21.89; p = 0.003), 
when compared to all other cohorts (denoted as non-obese class III) (Table 1, Figure 2). 
However, for the cohort divided as either obese (all-inclusive BMI ≥ 30.00) vs non-obese 
(all-inclusive BMI < 30.00) there were no significant differences in OR for either SSSI (1.54 
(95% CI [0.62, 3.81, p = 0.389) or DSSI (1.14 [95% CI [0.37 to 3.50, p = 1.000).  
 
BMI Normal Overweight Obese class I Obese class II Obese class III 
Patients % (n) 9.8 (82) 31.7 (266) 30.9 (259) 19.0 (159) 8.7 (73) 
30 day SSSI % (n) 1.2 (1) 2.3 (6) 1.5 (4) 3.1 (5) 8.2 (6)  
1 year DSSI % (n) 1.2 (1) 1.5 (4) 0.8 (2) 0.6 (1) 6.8 (5) 
SSSI: Superficial Surgical Site Infection; DSSI: Deep Surgical Site Infection 
 
Table 1: Total number of TKA patients grouped by obese class and infection type. Infection rate is expressed as 













3.3 Association between gender, obesity and SSI 
While there were no significant changes in infection rate between males and females (data 
not shown), there tended to be more females constituting the obese class III cohort (11.2%) 
than males (5.0%) (Table 2, Figure 1). In the obese class III cohort, SSSI rate was higher in 
females (8.9%) than males (5.9%) (Figure 3), yet DSSI was lower in females (5.4%) than 
males (11.8%) (Figure 4). For females the obese class III group had higher ORs for SSSI (OR 
= 5.32) and DSSI (OR = 6.20) (Table 2, Figure 2). In males, the obese class III group were at 
10.67 times greater odds of DSSI, compared to patients with a BMI of less than 40 (Table 2, 
Figure 2). No statistically significant difference was found for odds of SSSI in obese class III 
males, in comparison to non-obese class III males. It should be noted that 95% CIs of all ORs 
were wide, which limits findings. 
 
 Female Male 
 BMI<40 Obese class III BMI<40 Obese class III 
n 442 56 324 17 
SSSI % (n) 1.81 (8) 8.92 (5) 2.50 (8) 5.88 (1) 
OR (95%[CI]) 5.32 [1.68, 16.88] 2.47 [0.29, 20.97] 
p value 0.0096 0.372 
DSSI % (n) 0.90 (4) 5.35 (3) 1.20 (4) 11.76 (2) 
OR (95%[CI]) 6.198 [1.35, 28.46] 10.67 [1.81, 62.94] 
p value 0.034 0.031 
SSSI: Superficial Surgical Site Infection; DSSI: Deep Surgical Site Infection; Obese class III: BMI ≥ 40.00 
 
Table 2: Obese class III (BMI ≥ 40) vs Non-obese class III (BMI < 40) infection rates expressed by gender and 
infection type. Infection rates for SSSI and DSSI are expressed as a percentage (%). Odds ratio (OR) and 95% 












When cohorts were categorised as either obese (all-inclusive BMI ≥ 30.00) vs non-obese (all-
inclusive BMI < 30.00) and grouped by gender, there were no significant differences in either 
SSSI or DSSI observed (Table 3).  
 
 Female Male 
 BMI< 30.00 BMI ≥ 30.00 BMI< 30.00 BMI ≥ 30.00 
n 167 331 181 160 
SSSI % (n) 1.19 (2) 3.32 (11) 2.76 (5) 2.50 (4) 
OR SSSI (95%[CI]) 2.84 [0.621, 12.95] 0.903 [0.238, 3.422] 
p value 0.236 1.000 
DSSI % (n) 0.59 (1) 1.81 (6) 2.21 (4) 1.25 (2) 
OR DSSI (95%[CI]) 3.07 [0.366, 25.68] 0.560 [0.101, 3.10] 
p value 0.433 0.688 
SSSI: Superficial Surgical Site Infection; DSSI: Deep Surgical Site Infection 
 
Table 3: Infection rates for SSSI and DSSI by gender are expressed as a percentage (%). Odds ratio (OR) and 












Overweight and obesity are worldwide health epidemics with serious implications on the 
global health system. Obesity has been shown to be closely aligned with the incidence of 
osteoarthritis,3,4 whereby obese individuals of a younger age are more likely to require total 
joint arthroplasty and have a higher revision rate.5-7 Total joint replacement, although 
associated with improved quality of life outcomes, is a highly invasive surgery with risks of 
complication, such as those associated with SSSI or DSSI. As the incidence of obesity 
increases in the developed world, coupled with the ageing population, the demand for 
replacement surgeries is also on the rise.17 One common causative factor of prosthesis failure 
and revision is infection.17 Rather than assessing infection as an endpoint, studies involving 
obesity and TKA focus on outcomes of physical function scores or longevity of the 
prostheses.40 This highlights the need for an improved understanding of the incidence and 
risk factors associated with infection as a result of joint replacement surgery. 
This study demonstrated that overweight, obese class I and obese class II patients do not 
appear to have an increase in SSI rate compared to patients with normal or low BMI, 
demonstrated by assessing the potential association between SSSI and DSSI incidence in the 
obese vs non-obese TKA population. However, when assessing morbidly obese patients, the 
obese class III cohort demonstrated a significant association with SSI incidence consistent 
with the current literature, where morbid obesity has been shown to be associated with a 
higher incidence of post-surgery infection.41 This was particularly obvious in the female class 
III cohort with an increased incidence of SSSI and DSSI however the male class III cohort 
demonstrated an increased incidence in DSSI only. Interestingly there was increased odds of 
deep infection in the male cohort, yet not superficial infection. This presents an interesting 
point, however the wide confidence intervals reported limits this finding. Subcutaneous fat 
tissue depth has also been demonstrated as a contributing factor to SSI rate following cervical 
spine fusion42 and fat tissue depth around the knee has been suggested to be a potential 
measure of obesity.43 However, as male obese patients have reduced subcutaneous fat 
thickness around the knee joint compared to females, fat tissue depth may not be a 
contributing factor for increased deep infection in this instance, however requires further 
investigation.43 This finding may therefore indicate more complex systemic or metabolic 
factors, whereby increased postoperative pain and complication risk associated with obesity 











Interestingly, there have been a number of recent studies investigating the prevalence of 
multiple components of metabolic syndrome (MetS) and increased incidence of post-
operative complications including SSI.44,45 MetS, a diagnostic grouping of Diabetes Mellitus, 
dyslipidema, hypertension and obesity, has been of great interest with regard to its potential 
role in the pathogenesis of osteoarthritis and the associated systemic inflammatory state.46-48 
In addition, a recent study of the immune response in a rat model of MetS, found rats 
challenged with S. aureus had higher systemic levels of bacteria, pro-inflammatory cytokines 
and chemokines 48 hours after infection compared to non-MetS.49 Together these studies 
suggest that MetS may contribute to an altered systemic inflammatory state, increasing risk of 
a number of post-surgical complications including infection. However, an improved 
understanding of the molecular link between obesity, MetS and infection is still required. 
Furthermore, S. aureus nasal carriage is more likely in the obese population50 and this may 
partially influence the increase in SSI among obese patients, as S. aureus is a common 
pathogen in SSI. Another potential confounding factor is under-dosing of prophylactic 
antibiotics in obese patients, as a recent review of antibiotic dosing in an emergency 
department illustrated that doses given to obese patients were as low as 2-8% compliant with 
the hospital’s established protocol.51 
There are also increased costs and burden placed on the healthcare system associated with 
increased infection rates that need to be considered. While not as serious as deep infection, 
superficial infection may increase the cost and length of hospital stay, readmission rates and 
additional surgeries.52 This presents the complex question of whether obese or morbidly 
obese patients should have joint replacement surgery, as infection is only one of a number of 
potential complications that these patients may face,53 however further discussion of this 
concept is not within the scope of the present study. 
There are a number of limitations to consider, most significantly due to retrospective nature 
of this study. Firstly, confounding variables such as comorbidities including Diabetes 
Mellitus were unable to be accounted for, limiting the conclusions that can be drawn from 
this study. The retrospective study design also provides the potential for SSI to have been 
underreported. In addition, underweight individuals were not explicitly defined and it is 
unclear if any such patients were included in the normal body weight cohort. Previous studies 
have identified underweight or malnourished patients are at a higher risk of morbidity and 











54,55 Furthermore, BMI was the only identifier of obesity, thus additional measures should be 
considered for accurate classification of obese patients in future assessments.  
 
5. Conclusion 
The present study demonstrated a higher incidence of SSI, both superficial and deep, in 
primary TKA obese class III patients and an unchanged rate of infection in overweight, obese 
class I and obese class II patients when compared to the normal weight cohort. Interestingly 
male obese class III patients had the highest rate of deep SSI infection suggesting the 
systemic effects of obesity are more important than gender specific body habitus, however 
this requires further investigation. 
Furthermore, confounders such as comorbidity were unable to be accounted for, limiting 
plausible inference. Infection in obesity remains a challenge, and an improved understanding 
of the relationship and the mechanism by which morbid obesity in particular, appears to 
contribute to SSI requires further investigation. Additionally, the clinical management of 
orthopaedic surgery should continue to take into account patient obesity class in relation to 
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Figure 1. Gender distribution across BMI cohorts. 
 
Figure 2: Forrest Plot demonstrating the odds ratio between obese class III and non-obese 
class III, for SSSI and DSSI. Error bars show 95% confidence interval (CI). Infections with a 
95% CI that crosses the y-axis have a non-significant odds ratio. 
 
Figure 3. Superficial SSI rate (%) by gender distribution across BMI cohorts. 
 
Figure 4. Deep SSI rate (%) by gender distribution across BMI cohorts. 
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